Basecamp Research raised $140M and set out an EDEN-designed therapeutic pipeline.
The Series C was led by S32 with NVIDIA and others. The page describes EDEN, a biological foundation model for therapeutic design, and the Trillion Gene Atlas, a training dataset built from partnerships in 30+ countries. It also mentions a collaboration with Anthropic on Claude Science for generating therapeutic candidates, with in vivo cell therapy as the primary focus.
Basecamp Research is a London and Boston biology AI company that trains EDEN foundation models on proprietary evolutionary genomic data for therapeutic and enzyme design.
This sits in the Build stage of the AI use-case lifecycle: Named examples from the foundation-model labs and platforms pharma teams use to actually construct, train and generate the model or application.
Published by Basecamp Research on its own site — read the original case study on basecamp-research.com ↗
Related use cases
- 01Basecamp Research built a genomic data pipeline on Azure to train its EDEN foundation models.
- 02Basecamp Research and P&G partnered to design cold-water laundry enzymes with AI.
- 03OpenAI's dedicated healthcare vertical page/launch post.
- 04Frontier reasoning model built for biology, drug discovery and translational medicine; named qualified customers include Amgen, Moderna, Allen Institute, and Thermo Fisher Scientific.
- 05follow-up update to the life-sciences model.
- 06"How Amgen uses GPT-5": Amgen applies GPT-5/frontier models to help accelerate delivery of potential new therapies; found GPT-5 met scientific-accuracy standards.